Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

Share Price is delayed by 15 minutes
Get Live Data
1,394.40    -17.40 (-1.23%)
Bid:
1,394.40
Ask:
1,394.60
Spread: 0.20 (0.014%)
Market Cap: £115.57b
RR. Live PriceLast checked at - London Stock Exchange

Intraday Rolls-Royce Share Chart

Trent 1000 Package C Update

13 Apr 2018 07:00

RNS Number : 7993K
Rolls-Royce Holdings plc
13 April 2018
 

13 April 2018

TRENT 1000 PACKAGE C UPDATE

 

At our 2017 Full Year results on 7 March 2018 we outlined our management of certain Trent 1000 engine in-service issues and the estimated costs relating to our implementation of the solutions to address those issues.

 

As part of our ongoing inspection and testing of those engines we have decided to carry out additional engine inspections to those previously planned. The increased inspection frequency is driven by our further understanding of the durability of the Trent 1000 Package C compressor, a condition that we highlighted earlier this year. These inspections will be supported by service management and flight operations guidance to airlines to be issued by the airworthiness authorities.

 

This will unfortunately lead to additional disruption for our customers. There are 380 Package C engines currently in-service with airlines. This new regime does not impact Trent 1000 Package B engines or Trent 1000-TEN engines. 

 

While the compressor technical issue was known at the time of our results, the requirement for more regular inspections will lead to higher than previously guided cash costs being incurred during 2018. We are reprioritising various items of discretionary spend to mitigate these incremental cash costs and our guidance for 2018 FCF remains unchanged at Group FCF for 2018 of around £450m +/- £100m.

 

Warren East, CEO, Rolls-Royce, said: "Our focus is on supporting our customers and doing all we can to minimise any impact on their operations. We sincerely regret the disruption this will cause to our customers and our team of technical experts and service engineers is working around the clock to ensure we return them to full service as soon as possible. We will be working closely with Boeing and affected airlines to minimise disruption wherever possible."

 

Further information can be found at www.rolls-royce.com

 

 

About Rolls-Royce Holdings plc

 

1. Rolls-Royce pioneers cutting-edge technologies that deliver the cleanest, safest and most competitive solutions to meet our planet's vital power needs.

 

2. Rolls-Royce has customers in more than 150 countries, comprising more than 400 airlines and leasing customers, 160 armed forces, 4,000 marine customers including 70 navies, and more than 5,000 power and nuclear customers.

 

3. Annual underlying revenue was £15 billion in 2017, around half of which came from the provision of aftermarket services. The firm and announced order book stood at £78.5 billion at the end of December 2017.

 

4. In 2017, Rolls-Royce invested £1.4 billion on research and development. We also support a global network of 31 University Technology Centres, which position Rolls-Royce engineers at the forefront of scientific research.

 

5. Rolls-Royce employs almost 50,000 people in 50 countries. More than 16,500 of these are engineers.

 

6. The Group has a strong commitment to apprentice and graduate recruitment and to further developing employee skills. In 2016 we recruited 274 graduates and 327 apprentices through our worldwide training programmes.

 

 

 

For further information, please contact:

 

Investors:

Jennifer Ramsey +44 20 7227 9087

Ross Hawley +44 20 7227 9282

 

Media:

Richard Wray +44 20 7227 9163

 

www.Rolls-Royce.com

 
This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMDZZDGRZZ
Date   Source Headline
17th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 202611:00 amRNSDirector/PDMR Shareholding
11th Jun 20263:30 pmRNSDirector/PDMR Shareholding
10th Jun 20265:34 pmRNSTransaction in Own Shares
9th Jun 20264:30 pmRNSDirector/PDMR Shareholding
5th Jun 20263:30 pmRNSDirector/PDMR Shareholding
1st Jun 20263:00 pmRNSTotal Voting Rights
29th May 20263:30 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
8th May 20263:00 pmRNSDirector/PDMR Shareholding
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20263:30 pmRNSDirector/PDMR Shareholding
1st May 202610:30 amRNSTotal Voting Rights
30th Apr 20263:00 pmRNSResult of AGM
30th Apr 20267:00 amRNSAGM Statement and Trading Update
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20262:00 pmRNSDirector/PDMR Shareholding
22nd Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20264:30 pmRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 202612:00 pmRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 202611:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20264:00 pmRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20264:30 pmRNSDirector/PDMR Shareholding
10th Mar 20264:30 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 202611:00 amRNSAnnual Report 2025 and Annual General Meeting 2026

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.